NEW YORK, May 27, 2011 /PRNewswire/ -- The Medicines
Company (NASD:MDCO) will replace RehabCare Group Inc. (NYSE:RHB) in
the S&P SmallCap 600 index after the close of trading on
Wednesday, June 1, 2011.
RehabCare Group is being acquired by S&P MidCap 400
constituent Kindred Healthcare Inc. (NYSE:KND) in a deal expected
to be completed on or about that date pending final approvals.
Standard & Poor's will monitor this transaction, and post
any relevant updates on its website: www.standardandpoors.com.
The Medicines Company operates as a global pharmaceutical
company with a focus on advancing the treatment of critical care
patients. Headquartered in Parsippany, NJ, the company will be added to
the S&P SmallCap 600 GICS (Global Industry Classification
Standard) Pharmaceuticals Sub-Industry index.
Following is a summary of the change:
|
|
S&P
SMALLCAP 600 INDEX – June 1, 2011
|
|
|
COMPANY
|
GICS
ECONOMIC SECTOR
|
GICS
SUB-INDUSTRY
|
|
ADDED
|
The
Medicines Company
|
Health
Care
|
Pharmaceuticals
|
|
DELETED
|
RehabCare
Group
|
Health
Care
|
Health Care
Services
|
|
|
|
|
|
|
|
For more information about S&P Indices, please visit
www.standardandpoors.com/indices.
About S&P Indices
S&P Indices, the world's leading index provider, maintains a
wide variety of investable and benchmark indices to meet an array
of investor needs. Over $1.25
trillion is directly indexed to Standard & Poor's family
of indices, which includes the S&P 500, the world's most
followed stock market index, the S&P/Case-Shiller Home Price
Indices, the leading measure of U.S. home prices, the S&P
Global BMI, an index with approximately 11,000 constituents, the
S&P GSCI, the industry's most closely watched commodities
index, and the S&P National AMT-Free Municipal Bond Index, the
premier investable index for U.S. municipal bonds. For more
information, please visit www.standardandpoors.com/indices.
For more information contact:
David M. Blitzer, Ph.D.
Managing Director & Chairman of the Index Committee
(212) 438-3907
SOURCE Standard & Poor's